 |
|
|
| |
Human safety, pharmacokinetics and antiviral activity of
TMC647055, a novel HCV non-nucleoside polymerase inhibitor
|
| |
| |
Reported by Jules Levin AASLD 2011 Nov 6-9 San Francisco
J. Leempoels1, H. Reesink2, S. Bourgeois3, L. Vijgen4, MC. Rouan4, A. Vandebosch4, G. Ispas4, K. Marien4, P. Van Remoortere5, G. Fanning4, K. Simmen4, R. Verloes4
1SGS Life Science Services, Antwerp, Belgium, 2Department Gastroenterology and Hepatology AMC, Amsterdam, the Netherlands, 3ZNA Stuivenberg, Antwerp, Belgium, 4Tibotec BVBA, Beerse, Belgium, 5Tibotec Inc, Titusville, USA.
email corresponding author: rverloes@its.jnj.com
|
| |
|
|
|
|
|
